Company profile: Ultromics
1.1 - Company Overview
Company description
- Provider of AI-powered echocardiography software to assist cardiovascular disease diagnosis, supporting clinicians in interpreting echocardiogram data using machine learning to detect patterns and abnormalities. Products include EchoGo Core for automated analysis measuring left ventricular function and EchoGo Pro for AI detection of heart failure with preserved ejection fraction (HFpEF).
Products and services
- AI-Powered Echocardiography Interpretation Platforms: Delivers clinician support by applying machine learning to echocardiogram data to detect patterns and abnormalities indicating heart conditions
- EchoGo Core: Automates analysis of echocardiograms to measure left ventricular function for cardiovascular diagnosis support, applying AI to streamline interpretation, machine-learning–based
- EchoGo Pro: Uses AI for the detection of heart failure with preserved ejection fraction (HFpEF) from echocardiograms, assisting clinicians in identifying suspected cases, AI-driven.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ultromics
NantHealth
HQ: United States
Website
- Description: Provider of an evidence-based healthcare diagnostics and decision-support platform, offering Eviti Connect for oncology and autoimmune treatment validation and reimbursement; NaviNet Open for secure, real-time payer–provider exchange of administrative and clinical information; NaviNet AllPayer Advantage for eligibility, benefits, and claim status across over 1,000 commercial and state Medicaid plans; and OpenNMS for enterprise-scale network monitoring.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NantHealth company profile →
DXS Systems
HQ: United Kingdom
Website
- Description: Provider of healthcare IT and digital health solutions for clinicians and patients, offering software tools that provide healthcare resources, along with clinical assurance, data security, and privacy services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DXS Systems company profile →
Annkissam
HQ: United States
Website
- Description: Provider of innovative, affordable technology for mission-driven organizations, specializing in workflow software for Home and Community-Based Services and FMS in self-direction. Solutions include homecare management software linking providers, Medicaid and managed care with caregivers; real-time clinical information systems; BI dashboards; a Partner Connect program for HHAeXchange integration; and provider resources and guides.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Annkissam company profile →
Craneware
HQ: United Kingdom
Website
- Description: Provider of automated value cycle software and professional services for healthcare. Offers the Trisus Pricing Integrity, Business of Pharmacy, Value-based Margin and Productivity, and Data Integrity suites, plus Central Pharmacy Distribution (CPD) to integrate 340B and non-340B drug distributions for inventory management and 340B compliance, and services for strategic analysis, process design, and training.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Craneware company profile →
Noona
HQ: Finland
Website
- Description: Provider of a mobile service giving cancer centers a real-time, holistic view of patient wellbeing, with real-time symptom reporting and communication, structured data capture, automated workflow prioritization, over 31 prebuilt treatment modules covering more than 97 cancer types, remote rapid deployment, and real world evidence and outcomes data.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Noona company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ultromics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ultromics
2.2 - Growth funds investing in similar companies to Ultromics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ultromics
4.2 - Public trading comparable groups for Ultromics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →